Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2483 Views
-
Last post by NHE
-
- 0 Replies
- 1153 Views
-
Last post by frodo
-
- 0 Replies
- 1097 Views
-
Last post by NHE
-
- 0 Replies
- 1279 Views
-
Last post by frodo
-
- 0 Replies
- 1413 Views
-
Last post by NHE
-
- 0 Replies
- 1157 Views
-
Last post by frodo
-
- 0 Replies
- 2514 Views
-
Last post by NHE
-
- 0 Replies
- 1477 Views
-
Last post by NHE
-
- 0 Replies
- 1740 Views
-
Last post by DIM